Health

The use of antipsychotics in dementia patients has long been a topic of concern due to potential adverse outcomes. A recent population-based matched cohort study from the U.K. shed light on the increased risk associated with antipsychotic use in this vulnerable population. The study, which included more than 170,000 adults with dementia, revealed that those
0 Comments
Dallas anesthesiologist Raynaldo Rivera Ortiz Jr., MD, has recently been convicted for his actions that led to the death of a coworker and several cardiac emergencies involving patients. This shocking incident sheds light on the importance of medical professionals following proper protocols and ensuring patient safety at all times. In another troubling case, two doctors
0 Comments
The frustration and challenges associated with prior authorization for newer, highly effective cholesterol-lowering drugs are still prevalent in the medical field. Despite some improvements in access to these medications, the process remains arduous and time-consuming for healthcare providers. Dr. Christie Ballantyne of Baylor College of Medicine in Houston expressed his discontent with the current state
0 Comments
The testimony given by Republican lawmakers during the hearing of the House Committee on Oversight and Accountability highlights the challenges faced by the FDA with regards to the authorization of COVID-19 vaccines. Rep. Paul Gosar criticized the FDA for granting emergency use authorization of the vaccines, arguing that they do not stop virus transmission and
0 Comments
In a recent analysis of hospital websites, it was discovered that nearly all hospital websites transferred user information to third parties, yet almost one-third of these websites did not have a privacy policy in place. This is a concerning finding, as privacy policies are essential for informing users about how their data is being collected,
0 Comments
A recent pilot study conducted in San Diego showcased the safety and efficacy of a preoperative combination of chemotherapy and immunotherapy for patients with borderline resectable pancreatic cancer. The neoadjuvant treatment involved modified FOLFIRINOX (5-fluorouracil with leucovorin, irinotecan, and oxaliplatin) along with nivolumab (Opdivo) and yielded promising results. The median progression-free survival was 21.9 months,
0 Comments